High level expression, purification and activation of human dipeptidyl peptidase I from mammalian cells

McGuire, 1992, Purification and characterization of dipeptidyl peptidase I from human spleen, Arch. Biochem. Biophys., 295, 280, 10.1016/0003-9861(92)90519-3

Molgaard, 2007, The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2, Biochem. J., 401, 645, 10.1042/BJ20061389

Turk, 2001, Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases, EMBO J., 20, 6570, 10.1093/emboj/20.23.6570

Olsen, 2001, Tetrameric dipeptidyl peptidase I directs substrate specificity by use of the residual pro-part domain, FEBS Lett., 506, 201, 10.1016/S0014-5793(01)02911-8

Santilman, 2002, Importance of the propeptide in the biosynthetic maturation of rat cathepsin C, Eur. J. Cell Biol., 81, 654, 10.1078/0171-9335-00291

Cigic, 2000, The residual pro-part of cathepsin C fulfills the criteria required for an intramolecular chaperone in folding and stabilizing the human proenzyme, Biochemistry, 39, 12382, 10.1021/bi0008837

Dolenc, 1995, Oligomeric structure and substrate induced inhibition of human cathepsin C, J. Biol. Chem., 270, 21626, 10.1074/jbc.270.37.21626

Lauritzen, 1998, Active recombinant rat dipeptidyl aminopeptidase I (cathepsin C) produced using the baculovirus expression system, Protein Expr. Purif., 14, 434, 10.1006/prep.1998.0976

Lindley, 1972, The specificity of dipeptidyl aminopeptidase I (cathepsin C) and its use in peptide sequence studies, Biochem. J., 126, 683, 10.1042/bj1260683

McDonald, 1969, New observations on the substrate specificity of cathepsin C (dipeptidyl aminopeptidase I). Including the degradation of beta-corticotropin and other peptide hormones, J. Biol. Chem., 244, 2693, 10.1016/S0021-9258(18)83453-6

Metroione, 1966, Purification and properties of dipeptidyl transferase (Cathepsin C), Biochemistry, 5, 1597, 10.1021/bi00869a021

Mallen-St, 2004, Mast cell dipeptidyl peptidase I mediates survival from sepsis, J. Clin. Invest., 113, 628, 10.1172/JCI200419062

Pagano, 2007, Critical role of dipeptidyl peptidase I in neutrophil recruitment during the development of experimental abdominal aortic aneurysms, Proc. Natl. Acad. Sci. USA, 104, 2855, 10.1073/pnas.0606091104

Hu, 2005, Dipeptidyl peptidase I regulates the development of collagen-induced arthritis, Arthritis Rheum., 52, 2553, 10.1002/art.21192

Adkison, 2002, Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis, J. Clin. Invest., 109, 363, 10.1172/JCI0213462

Laine, 2010, Inhibitors of cathepsin C (dipeptidyl peptidase I), Expert Opin. Ther. Pat., 20, 497, 10.1517/13543771003657172

Pottier, 2007, Relationships between early inflammatory response to bleomycin and sensitivity to lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloproteinase-3?, Am. J. Respir. Crit Care Med., 176, 1098, 10.1164/rccm.200607-1051OC

Pedersen, 1999, Removal of N-terminal polyhistidine tags from recombinant proteins using engineered aminopeptidases, Protein Expr. Purif., 15, 389, 10.1006/prep.1999.1038

Lauritzen, 1991, BPTI and N-terminal extended analogues generated by factor Xa cleavage and cathepsin C trimming of a fusion protein expressed in Escherichia coli, Protein Expr. Purif., 2, 372, 10.1016/1046-5928(91)90096-2

Hsiung, 1987, Expression of bovine growth hormone derivatives in Escherichia coli and the use of the derivatives to produce natural sequence growth hormone by cathepsin C cleavage, Methods Enzymol., 153, 390, 10.1016/0076-6879(87)53067-1

Arnau, 2006, Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins, Protein Expr. Purif., 48, 1, 10.1016/j.pep.2005.12.002

Dalboge, 1987, A novel enzymatic method for production of authentic hgh from an Escherichia-coli produced hgh-precursor, Bio-Technology, 5, 161, 10.1038/nbt0287-161

Qiu, 2009, Expression and purification of active recombinant cathepsin C (dipeptidyl aminopeptidase I) of kuruma prawn Marsupenaeus japonicus in insect cells, J. Biomed. Biotechnol., 2009, 746289, 10.1155/2009/746289

Komeda, 2002, Production of active bovine cathepsin C (dipeptidyl aminopeptidase I) in the methylotrophic yeast Candida boidinii, Appl. Microbiol. Biotechnol., 59, 252, 10.1007/s00253-002-1010-z

Dahl, 2001, Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing, Biochemistry, 40, 1671, 10.1021/bi001693z

McGuire, 1997, Cloning and characterization of the cDNA encoding mouse dipeptidyl peptidase I (cathepsin C), Biochim. Biophys. Acta, 1351, 267, 10.1016/S0167-4781(97)00021-3

Smyth, 1995, Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I, J. Immunol., 154, 6299, 10.4049/jimmunol.154.12.6299

Y. Durocher, New nucleotide sequence coding for truncated Epstein–Barr Nuclear Antigen 1 (EBNA1) protein associated with increased gene expression, useful producing cell lines with better growth properties and enhanced transient gene expression, WO2006096989.

Stephens, 1989, The construction of a highly efficient, versatile set of mammalian expression vectors, Nucleic Acids Res, 17, 7110, 10.1093/nar/17.17.7110

Harfst, 1992, The use of the amplifiable high-expression vector pEE14 to study the interactions of autoantibodies with recombinant human thyrotrophin receptor, Mol. Cell Endocrinol., 83, 117, 10.1016/0303-7207(92)90152-V

Cigic, 1998, Stoichiometry and heterogeneity of the pro-region chain in tetrameric human cathepsin C, Biochim. Biophys. Acta, 1382, 143, 10.1016/S0167-4838(97)00173-8

Yates, 1985, Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells, Nature, 812, 10.1038/313812a0

Durocher, 2002, High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells, Nucleic Acids Res., 30, E9, 10.1093/nar/30.2.e9

de la Cruz Edmonds, 2006, Development of transfection and high-producer screening protocols for the CHOK1SV cell system, Mol. Biotechnol., 34, 179, 10.1385/MB:34:2:179

Jun, 2005, Selection strategies for the establishment of recombinant Chinese hamster ovary cell line with dihydrofolate reductase-mediated gene amplification, Appl. Microbiol. Biotechnol., 69, 162, 10.1007/s00253-005-1972-8

Cockett, 1990, High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification, Biotechnology (NY), 8, 662, 10.1038/nbt0790-662

Kaufman, 2000, Overview of vector design for mammalian gene expression, Mol. Biotechnol., 16, 151, 10.1385/MB:16:2:151

Li, 2005, Increasing the culture efficiency of hybridoma cells by the use of integrated metabolic control of glucose and glutamine at low levels, Biotechnol. Appl. Biochem., 42, 73, 10.1042/BA20040203